What's new

Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised

May 19, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Adempas, riociguat, Da...

Next Article

Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya va...

Related Posts

Summary of changes to the ‘External guidance on the imp...

May 15, 2025  0

Standard operating procedure for validation, publicatio...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0